Summary: Restoring sight to the blind through brain implants is a futuristic goal facing a very physical hurdle: the brain’s immune system. A new study has deconstructed the “standard” approach to neural implants to find a better way.
The research provides a rigorous comparison between stiff silicon electrodes and flexible polyimide probes, offering a “guidebook” for engineers to create devices that can survive in the brain long-term without causing debilitating scarring.
Key Findings:
- Material is King: The choice of flexible material (polyimide) was the single most important factor in reducing tissue damage.
- Size vs. Usability: Surprisingly, making probes “ultra-thin” or allowing them to “float” wirelessly didn’t significantly reduce scarring. This is a win for surgeons: it means they can use probes that are slightly thicker and easier to handle without sacrificing the patient’s brain health.
- The White Matter Barrier: The team found that the brain reacts most violently when an implant disturbs the boundary between grey matter (processing) and white matter (wiring). Avoiding this boundary is critical for a stable implant.
- Stabilization: After an initial “alarm” phase from the immune system, the brain appears to stabilize around polyimide probes, suggesting they could function for years, long enough to be practical for a visual prosthesis.
Source: KNAW
In laboratories around the world, scientists are working on a bold goal: restoring blindness using brain implants. But behind the futuristic promise lies a quieter, more complicated story about materials, assumptions, and the limits of what we really understand about the brain.
One part of this story includes a deceptively simple question: how do you place a foreign object in the brain without evoking a reaction?
The Problem with “Good Enough”
For years, the standard technology in neural implants has relied on stiff silicon electrodes. While these devices are already used for severe brain disorders, the repercussions are high.
“We know that they cause damage and stop working after a while,” Roxana Kooijmans, last-author and histology expert, explains. The brain reacts to foreign objects, and over time, that reaction can degrade both the tissue and the device’s performance.
Kooijmans shows an image of a brain that has been implanted with three stiff silicon electrodes. “The three clusters of yellow and pink shapes are the brain’s reaction to the material of an implant that will ultimately cause major scarring and stop functioning”, she explains.
“We are invested in really making an improvement in people’s lives by developing an implant for the blind”, Pieter Roelfsema, last author and prosthesis innovator emphasises. Roelfsema is overviewing a substantial effort in bringing visual brain implants to the patient, looking into the future of brain machine interfaces.
In clinical contexts where patients have few alternatives, that trade-off may be acceptable. But for something like a visual prosthesis, intended to improve quality of life over the long term, that calculation changes.
“This is really just… something that has to be a win,” Kooijmans says. “Compared to people with debilitating movement or mood disorders, blind individuals have a relatively good quality of life, and there are a lot of social compensatory mechanisms for them to live independently”.
A Promising Alternative—But Not a Miracle
This is where polyimide probes come in. These are flexible, softer implants designed to better match the brain’s delicate structure. In the field, they’ve gained a reputation as the future of neural interfaces.
There’s just one problem: the evidence hasn’t always kept up with the enthusiasm. “There’s this general consensus that they are better for the brain,” Corinne Orlemann, first author, notes. “and while there is evidence towards this claim, no one did a fully systematic comparison between these designs.”
Some earlier studies even suggested that these softer materials caused little to no reaction in the brain. According to Kooijmans, that conclusion may have been based on incomplete methods. “There is reactivity of the brain… it’s there, it was just not mapped”
Looking Closer—Literally
Part of the issue lies in how scientists have examined this approach so far. Many studies sliced the brain in ways that obscured important changes. “You have exactly zero overview,” Kooijmans explains. “The depth prediction is wrong. You might think you’re in one layer, but you’re actually much deeper.”
By rethinking how tissue is analysed, and applying more rigorous, quantitative methods, the team uncovered a more nuanced picture. Polyimide probes do provoke a response from the brain, but significantly less than their silicon counterparts.
“It works better,” Orlemann says. “But it is not a miracle cure.”
What Actually Matters
Orlemann tested multiple variables: material, size, thickness, and even how the implant is attached. The material was indeed the most important factor.
Surprisingly, other factors, like making probes thinner or detaching them from the skull to “float” with the brain, had far less impact than expected. That insight has practical consequences. Engineers no longer need to aim for the smallest possible implant at the cost of usability, nor do they need to be wireless.
“If you make them very thin, implantation gets harder and harder,” Orlemann explains. “But now that we know there is no real point, we can bypass that aim and increase our surgery success.”
One of the team’s most surprising findings involves the boundary between grey matter (where neurons process information) and white matter (which connects brain regions). When implants disturb this boundary, the brain reacts more strongly. This reaction can trigger a cascade of immune responses, disrupting the delicate balance needed for the cells to function properly.
From Trial-and-Error to a “Guidebook”
Historically, much of this field has advanced through trial and error, often driven by urgent clinical needs. But this study aims to change that by offering a clearer roadmap. “This study is a bit of a guidebook of reasonable compromises,” Orlemann explains.
By identifying which design choices truly matter (and which don’t) this research narrows the path forward. That could save time, reduce costs, and accelerate the development of real-world devices.
“We have fewer directions that we need to invest in,” Kooijmans notes. “That means we get closer to a working prototype.”
The Road Ahead
For now, the work continues in animal models, where researchers can carefully track long-term effects. And the findings are definitely encouraging. After an initial immune response, the brain appears to stabilize.
The next steps involve refining the functional devices. Implants that don’t just sit in the brain, but actively stimulate it to produce visual experiences.
If there’s one message the researchers want to emphasize, it’s precision—beyond optimism, minute attention to detail. “People really, really want this to work,” Kooijmans reflects.
“It works. In fact, it works better than anything else we have, and the trade-off might just be small enough”.
“We understand where we need to direct our attention to make effective progress. We have the right material, and we know both its merits and minor drawbacks, so now we need to achieve the best probe design and implant strategy”, Roelfsema completes.
That shift, from hype to careful understanding, may ultimately be what brings visual prostheses from the lab into everyday life. Because in the brain, even the smallest details matter.
Key Questions Answered:
A: The brain is evolved to protect itself. Any foreign object is seen as a potential infection or injury. Scientists aren’t trying to make the brain “ignore” the implant anymore; they are trying to make the implant so soft and compatible that the brain’s reaction is a minor “nudge” rather than a massive, permanent scar.
A: We aren’t at “HD vision” yet. Early versions provide “phosphenes”—small dots of light that act like pixels on a scoreboard. By using these new flexible materials, we can pack more pixels into the brain safely, making the “image” much clearer and more stable over time.
A: Silicon is very easy to manufacture and has been the industry standard for 30 years. Moving to polyimide requires new surgical techniques and manufacturing pipelines. This study provides the “hard data” needed to convince the industry to finally make the switch.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neurotech and brain implant research news
Author: Eline Feenstra
Source: KNAW
Contact: Eline Feenstra – KNAW
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Friend, Not Foe: Lowered Tissue Reactivity to Long-Term Polyimide Implants” by Corinne Orlemann, Laura M. De Santis, Paul Neering, Christian Boehler, Kirti Sharma, Arno Aarts, Tobias Holzhammer, Rik J. J. van Daal, Patrick Ruther, Maria Asplund, Roxana N. Kooijmans, Pieter R. Roelfsema. Advanced Science
DOI:10.1002/advs.202600028
Abstract
Friend, Not Foe: Lowered Tissue Reactivity to Long-Term Polyimide Implants
One of the biggest challenges for neurotechnology is the design of devices that are tolerated well by brain tissue, without sacrificing functionality and implantability. This study examined which design choices mitigate tissue damage and improve longevity by varying probe features implanted in the cerebral cortex of mice.
We report on a systematic, quantitative analysis of neuronal and inflammation markers across cortical depth. We implanted a total of 103 stiff silicon or flexible polyimide probes in 32 mice, varying their thicknesses and widths, and either attaching them to the skull or not.
A new, automated workflow to quantify immunohistochemical data examines: 1) the tissue loss caused by the implant, 2) the cortical neuronal density, and 3) the immune response expressed by astrocytic and microglial reaction. Flexible polyimide probes exhibited a clear advantage, causing fewer lesions and weaker immune responses than stiff silicon probes.
Furthermore, we observed a weak influence of the shank cross-section. A cortical depth profile of immune reactivity revealed focal reactions at the device entry points in the superficial cortex and at the cortex-white matter boundary.
This study gives important insights on optimizing device design parameters as well as surgical insights for improved tissue integration of intracortical electrode arrays.
